IV-275 is a dual inhibitor targeting the bromodomains of both BRG1 and BRM. This compound not only augments DNA damage when combined with Temozolomide and Bleomycin but also suppresses the invasiveness of GBM cells. Furthermore, IV-275 amplifies Temozolo
Molecular Weight:
360.35
Formula:
C19H18F2N2O3
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
